Javier Huete-Acervedo

Mr. Javier Huete-Acervedo

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Jorge Sanz RosJorge Sanz Ros
Jorge Sanz Ros
Cristina Mas-BarguesCristina Mas-Bargues
Cristina Mas-Bargues
NRNekane Romero-Garcia
Nekane Romero-Garcia
JHJavier Huete-Acervedo
Javier Huete-Acervedo
MDMar Dromant
Mar Dromant
Consuelo BorrasConsuelo Borras
Consuelo Borras
The native role of extracellular vesicles (EVs) in mediating the transfer of biomolecules between cells has raised the possibility to use them as therapeutic vehicles. The development of therapies based on EVs is now expanding rapidly; here we will describe the current knowledge on different key points regarding the use of EVs in a clinical setting. These points are related to cell sources of EVs, isolation, storage, and delivery methods, as well as modifications to the releasing cells for improved production of EVs. Finally, we will depict the application of EVs therapies in clinical trials, considering the impact of the COVID-19 pandemic on the development of these therapies, pointing out that although it is a promising therapy for human diseases, we are still in the initial phase of its application to patients.

Verified
Journal Article
Open access
PDF file
Jorge Sanz RosJorge Sanz Ros
Jorge Sanz Ros
Cristina Mas-BarguesCristina Mas-Bargues
Cristina Mas-Bargues
NRNekane Romero-Garcia
Nekane Romero-Garcia
JHJavier Huete-Acervedo
Javier Huete-Acervedo
MDMar Dromant
Mar Dromant
Consuelo BorrasConsuelo Borras
Consuelo Borras
The mitochondria play a crucial role in cellular metabolism, reactive oxygen species (ROS) production, and apoptosis. Aberrant mitochondria can cause severe damage to the cells, which have established a tight quality control for the mitochondria. This process avoids the accumulation of damaged mitochondria and can lead to the release of mitochondrial constituents to the extracellular milieu through mitochondrial extracellular vesicles (MitoEVs). These MitoEVs carry mtDNA, rRNA, tRNA, and protein complexes of the respiratory chain, and the largest MitoEVs can even transport whole mitochondria. Macrophages ultimately engulf these MitoEVs to undergo outsourced mitophagy. Recently, it has been reported that MitoEVs can also contain healthy mitochondria, whose function seems to be the rescue of stressed cells by restoring the loss of mitochondrial function. This mitochondrial transfer has opened the field of their use as potential disease biomarkers and therapeutic tools. This review describes this new EVs-mediated transfer of the mitochondria and the current application of MitoEVs in the clinical environment.

13 January 2023 in Biomolecules
Verified
Journal Article
Open access
PDF file
NRNekane Romero-Garcia
Nekane Romero-Garcia
JHJavier Huete-Acervedo
Javier Huete-Acervedo
Cristina Mas-BarguesCristina Mas-Bargues
Cristina Mas-Bargues
Jorge Sanz RosJorge Sanz Ros
Jorge Sanz Ros
MDMar Dromant
Mar Dromant
Consuelo BorrasConsuelo Borras
Consuelo Borras
The exponential growth in the elderly population and their associated socioeconomic burden have recently brought aging research into the spotlight. To integrate current knowledge and guide potential interventions, nine biochemical pathways are summarized under the term hallmarks of aging. These hallmarks are deeply inter-related and act together to drive the aging process. Altered intercellular communication is particularly relevant since it explains how damage at the cellular level translates into age-related loss of function at the organismal level. As the main effectors of intercellular communication, extracellular vesicles (EVs) might play a key role in the aggravation or mitigation of the hallmarks of aging. This review aims to summarize this role and to provide context for the multiple emerging EV-based gerotherapeutic strategies that are currently under study.

6 December 2024 in Antioxidants
Verified
Journal Article
Open access
PDF file
JHJavier Huete-Acervedo
Javier Huete-Acervedo
Cristina Mas-BarguesCristina Mas-Bargues
Cristina Mas-Bargues
MFMarta Arnal Forné
Marta Arnal Forné
SASandra Atencia-Rabadán
Sandra Atencia-Rabadán
JSJorge Sanz-Ros
Jorge Sanz-Ros
Consuelo BorrasConsuelo Borras
Consuelo Borras
Extracellular vesicles (EVs) are small, membrane-bound particles secreted by cells into the extracellular environment, playing an increasingly recognized role in inter-organ communication and the regulation of various physiological processes. Regarding the redox homeostasis context, EVs play a pivotal role in propagating and mitigating oxidative stress signals across different organs. Cells under oxidative stress release EVs containing signaling molecules that can influence the redox status of distant cells and tissues. EVs are starting to be recognized as contributors to brain-liver communication. Therefore, in this review, we show how redox imbalance can affect the release of EVs in the brain and liver. We propose EVs as mediators of redox homeostasis in the brain-liver axis.

29 April 2025 in Antioxidants
Verified
Journal Article
Open access
PDF file
Cristina Mas-BarguesCristina Mas-Bargues
Cristina Mas-Bargues
JHJavier Huete-Acervedo
Javier Huete-Acervedo
MAMarta Arnal-Forné
Marta Arnal-Forné
LSLaura Sireno
Laura Sireno
Virgilio PérezVirgilio Pérez
Virgilio Pérez
Consuelo BorrasConsuelo Borras
Consuelo Borras
Extracellular vesicles (EVs) are emerging as key regulators of cellular communication, with increasing evidence supporting their role in oxidative stress (OS) modulation. In particular, the miRNA cargo of EVs plays a crucial role in mitigating OS and promoting redox balance through both direct antioxidant effects and epigenetic regulation. This study aimed to evaluate the impact of EVs on OS markers, influenced by their miRNA-mediated effects and potential epigenetic modifications in target cells. A systematic literature search was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines to identify studies reporting the effects of EVs on OS parameters. A meta-analysis was performed on key OS biomarkers, including reactive oxygen species (ROS), superoxide dismutase (SOD), glutathione (GSH), and malondialdehyde (MDA). The heterogeneity of EV isolation and characterization techniques was also analyzed. The included studies demonstrated that EVs exert significant antioxidant effects by reducing ROS levels, increasing SOD activity and GSH levels, and lowering MDA levels. These effects were largely attributed to EV-miRNAs, which induce epigenetic modifications that modulate redox-related signaling pathways. However, the variability in EV isolation methods and characterization approaches highlights the need for standardization to improve data comparability. Despite their therapeutic potential, this significant heterogeneity in EV research remains a barrier to translation. Moreover, further exploration of epigenetic mechanisms is essential to fully harness their benefits for OS-related diseases.

Verified
Journal Article
Open access
PDF file
NRNekane Romero-Garcia
Nekane Romero-Garcia
JHJavier Huete-Acervedo
Javier Huete-Acervedo
Cristina Mas-BarguesCristina Mas-Bargues
Cristina Mas-Bargues
Jorge Sanz RosJorge Sanz Ros
Jorge Sanz Ros
MDMar Dromant
Mar Dromant
Consuelo BorrasConsuelo Borras
Consuelo Borras
Solid organ transplantation (SOT) is a life-saving treatment for end-stage organ failure, but it comes with several challenges, the most important of which is the existing gap between the need for transplants and organ availability. One of the main concerns in this regard is the lack of accurate non-invasive biomarkers to monitor the status of a transplanted organ. Extracellular vesicles (EVs) have recently emerged as a promising source of biomarkers for various diseases. In the context of SOT, EVs have been shown to be involved in the communication between donor and recipient cells and may carry valuable information about the function of an allograft. This has led to an increasing interest in exploring the use of EVs for the preoperative assessment of organs, early postoperative monitoring of graft function, or the diagnosis of rejection, infection, ischemia-reperfusion injury, or drug toxicity. In this review, we summarize recent evidence on the use of EVs as biomarkers for these conditions and discuss their applicability in the clinical setting.